<unk>  has been studied in men with advanced prostate cancer at massive dosages of 1,000 to 2,000 mg/day orally and 100 to 500 mg/day via intramuscular injection, without serious adverse effects or toxicity described.
Chlormadinone acetate
Methenmadinone acetate
Chlormethenmadinone acetate
Bolandiol dipropionate
Hydroxyprogesterone heptanoate
Ethinylestradiol sulfate
Ethinylestradiol sulfonate
Androstenediol dipropionate